Your browser doesn't support javascript.
loading
Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor ß.
Macchia, Enrico; Lombardi, Martina; Raffaelli, Valentina; Piaggi, Paolo; Macchia, Lorenzo; Scattina, Ilaria; Martino, Enio.
Afiliação
  • Macchia E; Department of Clinical and Experimental Medicine, Section of Endocrinology, University of Pisa, Pisa, Italy.
Clin Endocrinol (Oxf) ; 81(6): 921-8, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25040256
OBJECTIVE: The syndrome of resistance to thyroid hormone (RTH) is caused by a mutation of TH receptor ß (TRß) in 80% of cases. Patients without mutation (non-TR-RTH) may have a biochemical pattern that is difficult to differentiate from that of pituitary TSH-secreting adenoma (TSHoma). Herein, we report a large monocentric series of RTH focusing on patients with non-TR-RTH, to evaluate possible clinical or biochemical parameters able to distinguish them from TSHoma. DESIGN AND PATIENTS: We retrospectively reviewed the data of 99 consecutive patients with inappropriate TSH secretion (IST) syndrome referred to our Department between 1983 and 2011, identifying 68 patients with RTH and 31 patients with TSHomas. MEASUREMENTS: Patient records were reviewed for the main clinical, biochemical and imaging characteristics. RESULTS: Of our 68 patients with RTH, 16 (23·5%) did not show a TRß mutation and did not have affected family members. Of these 16 patients, three developed a TSHoma, during follow-up. To distinguish non-TR-RTH from TSHoma, we identified appropriate cut-off values for the main biochemical parameters that demonstrated the greatest sensitivity and specificity (T3 suppression test, α-subunit/TSH molar ratio, α-subunit assay and TRH test) and we calculated the probability for each patient to develop a TSHoma. CONCLUSIONS: The application of the identified cut-offs could become a very useful tool in the challenging differential diagnosis between sporadic non-TR-RTH and TSHoma. It would then be possible to select the patients at higher risk of developing a TSHoma and therefore needing a closer follow-up.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Tiroxina / Tri-Iodotironina / Tireotropina / Subunidade alfa de Hormônios Glicoproteicos / Adenoma / Receptores beta dos Hormônios Tireóideos / Hiperpituitarismo Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Tiroxina / Tri-Iodotironina / Tireotropina / Subunidade alfa de Hormônios Glicoproteicos / Adenoma / Receptores beta dos Hormônios Tireóideos / Hiperpituitarismo Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália